|
HS Code |
610698 |
| Iupac Name | 2-[2-(3-methoxyphenyl)ethyl]phenol |
| Molecular Formula | C15H16O2 |
| Cas Number | 42252-38-0 |
| Appearance | White to off-white solid |
| Solubility In Water | Low |
| Solubility In Organic Solvents | Soluble in chloroform, DMSO, and methanol |
| Logp | Estimated 3.1 |
| Pka | Estimated 9.8 (phenolic OH group) |
| Smiles | COC1=CC=CC(=C1)CC2=CC=CC=C2O |
| Inchi | InChI=1S/C15H16O2/c1-17-13-6-4-5-12(10-13)8-9-14-7-2-3-11-15(14)16/h2-7,10-11,16H,8-9H2,1H3 |
As an accredited 2-(2-(3-Methoxy)Phenylethyl)Phenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25-gram amber glass bottle with a tamper-evident cap and a clear, printed identification label. |
| Shipping | 2-(2-(3-Methoxy)Phenylethyl)Phenol is shipped in secure, chemical-resistant containers to prevent contamination and leakage. The packaging complies with hazardous material regulations, labeled appropriately with handling and hazard information. During transit, it is protected from extreme temperatures, moisture, and direct sunlight, ensuring safe delivery to laboratories or industrial locations. |
| Storage | Store 2-(2-(3-Methoxy)phenylethyl)phenol in a tightly closed container, in a cool, dry, and well-ventilated area away from direct sunlight and incompatible materials such as strong oxidizers and acids. Protect from moisture and heat sources. Label the container clearly, and ensure it is stored at a stable room temperature to prevent decomposition or unwanted reactions. |
Competitive 2-(2-(3-Methoxy)Phenylethyl)Phenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Day in and day out, we see shifts in customer demand for advanced intermediates like 2-(2-(3-Methoxy)Phenylethyl)Phenol. This molecule never stays in the background. We have watched its role grow across sectors: from pharma labs searching for cleaner synthetic building blocks, to research institutes digging deeper into action mechanisms for phenolic compounds.
Producing this product in-house gives us a direct line to the issues that matter most to formulators and lab managers. Every step, from raw material sourcing to final QA checks, takes shape in our own facilities. We drive continuous improvement through hands-on process control — the only way to keep up with evolving benchmarks for purity and batch stability.
In our latest batches, 2-(2-(3-Methoxy)Phenylethyl)Phenol presents itself as a pale, crystalline solid under standard storage conditions. Our chemists often note a faint aromatic odor, typical of alkylated phenols. Molecular formula C15H16O2, with a defined melting range and trusted GC-MS fingerprint—this profile helps our customers track down batch-to-batch consistency.
We run every drum through full spectrometric analysis before shipment. Impurity levels, water content, and residual solvents draw attention because they can impact further downstream chemistry—especially with sensitive palladium or nickel-based couplings. We hit isomeric purity above 98%, and aim for residual solvent content well below the detection limits written into most synthesis protocols.
Our technical team gets calls from labs and production sites using 2-(2-(3-Methoxy)Phenylethyl)Phenol in medicinal chemistry, discovery research, and pilot-scale API production. The methoxyphenyl motif crops up in a range of synthetic routes, often as a precursor for bioactive molecules. By providing this specific ethyl-bridged, methoxy-substituted phenol, we help researchers avoid laborious multi-step conversions starting from more basic aromatics.
This compound cuts down multi-stage procedures for adding an ethyl linker and a protected phenol group on a single molecular framework. Over the years, we have worked with process chemists scaling up projects from gram to kilogram levels. They tell us this intermediate reduces waste, shortens campaign time, and lessens risk of side reactions compared with older phenylethylphenol derivatives.
There’s a good reason researchers request this molecule by name, and it isn’t just the confidence that comes from high purity stats. We have seen, batch after batch, that regioselective placement of the methoxy group and ethyl bridge delivers far less byproduct formation. That matters most for teams working at the cutting edge, where one misplaced functional group can derail a synthesis pathway or poison a catalyst bed.
Other products on the market—standard phenylethylphenols, unprotected phenols, or even mono- or dimethoxy analogs—don’t always deliver selectivity or yield needed for next-step reactions. We’ve taken calls about failed couplings due to both over-reactivity and decomposition from trace contaminants. By keeping a close watch on each lot and using in-line purification, we sidestep many of the issues that plagued the field only a decade ago.
We handle our own reactions, starting from well-qualified methoxybenzene and phenol derivatives. Alkylation and selective substitution steps build the desired structure in a controlled series. It’s never a generic, contract job outsourced to bulk chemical plants. Every synthesis is run by our own team—many of whom have been with us for ten or more years. This means our adjustments in feedstock quality or process controls can take effect the same week a customer reports an out-of-spec phenomenon in their plant.
Sometimes we get requests for special grades—higher clarity, reduced metals, or added drying. Adjustments for these needs are realistic only because our plants have modular setups, not assembly lines built for volume at the expense of variability. Starting with smaller batch sizes avoids cross-contamination risk and lets us implement customer-driven process changes overnight. This level of flexibility comes from years spent building the process ourselves, not inheriting tools or standards from a third party.
Experience tells us analytics are often as important as the product itself. With every batch of 2-(2-(3-Methoxy)Phenylethyl)Phenol, we prepare a complete dossier—HPLC, GC-MS, and NMR profiles, with full traceability back to lot numbers and storage conditions. End-users in regulated environments insist on seeing this data for traceability and for seamless scale-up.
We field technical questions every week about specific isomer counts, methoxy/phenol substitution ratios, and allowable trace metals. Our analytical chemists keep direct communication with customers, sharing both historical data and real-time updates in each production cycle. For the most critical users, repeat testing on archival retains and live-pull samples gives added peace of mind—no one waits for a “third-party” answer.
Working in chemical production for decades, we recognize handling risks aren’t left to the last mile. The phenolic backbone of this product brings certain flammability and respiratory sensitization risks. As the manufacturer, we commit to hands-on safety for every stage, from in-plant transfer systems to triple-sealed drums. We outline guidance for safe storage and handling alongside every COA, derived from actual incident logs—not just textbook recommendations.
On the environmental front, the methoxy and phenolic functionalities signal a moderate persistence profile. We adjust process solvents and neutralization steps to curtail downstream waste. By retaining direct control, we supply recycling data and offer customers tailor-fit return or take-back plans for unused material. Only direct plant experience allows for this level of logistical alignment and transparency in sustainability reporting.
Most new applications for 2-(2-(3-Methoxy)Phenylethyl)Phenol come straight from direct conversations with R&D labs. We run small trial batches based on specific calls for higher or lower particle sizes, different solvent residues, or alternative packaging designed for automated systems. When a team in pharmaceutical research runs into purity drift after scale-up, we take that as a warning. Our teams trace back the full production record, making process changes on the same line without waiting for month-long review cycles.
Over the years, calls for improved shelf stability have prompted us to revisit crystallization and drying protocols. We have moved away from certain stabilization agents after customers flagged interference in their testing. Being both the producer and quality gatekeeper means new ideas reach the plant floor without needless delays. We watch incoming order patterns and adjust plant scheduling for customers who need rush production, recognizing that research windows can close fast.
Having produced this product in-house for years, we see how much time and troubleshooting gets lost to cleaning up after impure batches or failed couplings. We focus on eliminating such headaches before they start, keeping downstream steps as clean as possible. Countless conversations with process chemists and QC leads have shown us that a little more effort at the manufacturing stage often saves weeks—sometimes months—in development time.
We have sharp memories of past years, when customers tried combining off-the-shelf intermediates and ended up with muddy HPLC reads or unusable side fractions. Learning from those cases, we push continuous purification and never skimp on solvent stripping or final filtrates. That insistence on direct plant control lets us promise lower variability, easier filtration in later steps, less solvent hold-up, and fewer cloudy precipitation events.
Trying to produce this molecule at commercial scale brings a set of challenges that only experience can address. Small tweaks in feed rates, agitation speed, or temperature can swing the product quality, especially for the methoxy-phenol backbone. We spent months refining the loading protocols for our reactors to dial in the crystal form that won’t cake or degrade in shipment.
Customers in fine chemicals and active pharmaceutical ingredient sectors turn to us not just for the paperwork, but because we can solve problems before they take root. Our long-term team keeps track of anomalous test results, course-corrects for batch variation, and prioritizes direct feedback from the people using the product. We grow by solving actual synthesis problems, not by chasing minimum order quantities or commodity pricing.
Shifting manufacturing of 2-(2-(3-Methoxy)Phenylethyl)Phenol to a third party would hand over decisions on raw material grades, solvent handling, and process optimization to others. Over years of direct production, we have seen how easy it is for minute specification changes to creep in when you are removed from your own line. In contrast, by doing everything ourselves—from early reactions to finishing and packaging—we hold every lever, and customers notice the difference.
Some have tried other sources, then come back after struggling with inconsistent product color, less-than-complete GC profiles, or even batches that failed to meet their own research standards. Long relationships come out of this level of process control; our best innovations have come from working the production floor and blending customer application knowledge with practical chemical know-how.
Nearly all requests for 2-(2-(3-Methoxy)Phenylethyl)Phenol name their end-use. We hear from teams designing advanced pharmaceutical scaffolds, as well as those exploring new antioxidant formulations for industrial additives. The molecule’s specific electronic profile makes it valuable as both a coupling partner and as a test substrate for new biocatalytic systems.
When research teams embark on total syntheses, they cite fewer side reactions and easier workup than with unsubstituted relatives. Our close monitoring of substitution patterns cuts down on troublesome regioisomers. Application in catalysis sometimes requires stripping every trace of transition metals and halides—which pushes us to keep refining our plant processes. Every week, we’re working with someone tweaking their next big advance and, in turn, making improvements to our own routine.
Our plant experience leads us to use inner-sealed, inert-lined containers for all shipments. Years of customer feedback pointed out that even minor seal failures or off-gassing leads to product degradation—especially if the shipment crosses multiple climate zones. Specialized packaging holds up through these cycles, and we schedule shipment launches to avoid weekend storage or long customs delays.
We put most lots through accelerated aging tests, benchmarking shelf life under variable humidity and light conditions. Knowing that many users place product in cold or controlled temp lines, we opt for packaging formats that minimize thermal transfer. Experience has taught us that the right drum or sealed jar can boost in-field usability months beyond what standard open-container shipping could achieve.
With chemical innovation accelerating, we don’t see 2-(2-(3-Methoxy)Phenylethyl)Phenol fading anytime soon. Our R&D continues to explore greener routes: cutting down reaction steps, reducing energy usage, and swapping in new solvent systems. We develop upgrades directly on the line, moving quickly by learning from upstream and downstream feedback. Our teams stay sharp by tracking every gram of waste we generate, using that information to pivot processes in real time.
Regular audits, open plant tours for key partners, and a steady stream of hands-on training for every operator make us more than just a supplier. We put real numbers behind our process transparency—every product change is logged, scrutinized, and shared if it improves quality or lowers cost. This level of investment in people and process sets our production apart in a landscape full of anonymous batch manufactures.
In the specialty chemical sector, generic products often chase a one-size-fits-all approach. Years of collaboration with QC labs and pharma storage teams show us how rarely that works in practice. We don’t water down our standards to compete on short-term price, because the savings often evaporate once customers report reaction failures or missed benchmarks downstream.
Other market offerings sometimes assume one set of impurity targets fits all applications. Our experience shows that targeted adjustments, like lowering base metal contamination for enzymatic syntheses, can open new applications. This collaborative tailoring earns us steady repeat business from innovators unwilling to gamble with program timelines.
In every lot, our commitment touches off at the earliest step—selection of raw materials, real-time process monitoring, and sharp-eyed QA down to the package label. No product, no matter how refined, leaves our site without occupying hundreds of staff hours for testing, documentation, and review. This is how we live up to our responsibility—not through marketing, but through factory lights that run late and teams motivated by curiosity and pride.
For every new challenge—tighter specs, new impurity targets, evolving end-use trends—we’re at the table working with the chemists on the other end. Solving problems proactively means our partners spend fewer nights troubleshooting and more time driving research forward. That approach, born from experience, shapes every batch of 2-(2-(3-Methoxy)Phenylethyl)Phenol we produce.
